SyloSpace

How does a pacemaker work and what does it do when the heart beats too fast?

Pacemakers and defibrillators act on the heart's signals according to programmed timing, so unusual ECG patterns often reflect normal device behaviour rather than a fault.

Updated 1 hour ago6 min readVersion 2
CommentsFollow

Covers: How implanted pacemakers sense and pace the heart, the difference between pacing for slow rhythms and treatments for fast rhythms (antitachycardia pacing, defibrillation, and pacemaker-mediated tachycardia), and how devices are programmed. It does not cover surgical technique or individual treatment decisions.

Also answers: What does a pacemaker do for a fast heartbeat? · How do pacemakers sense and pace the heart? · Can a pacemaker slow down a fast heart rate? · Pacemaker vs ICD for fast heart rhythms

The short answer

Interpretation AI-prepared starting map

An implanted pacemaker watches the heart's own electrical activity and delivers small electrical pulses when the heart beats too slowly or when conduction fails. For fast rhythms the picture splits: pacemakers and defibrillators can deliver antitachycardia pacing (ATP) — rapid bursts of pacing intended to interrupt an arrhythmia — and defibrillators can…123

Read the full explanation and caveats
A portable medical monitor displaying vital signs with a yellow waveform on screen
Photo: Navy Medicine

At a glance

The picture in numbers

Live · updated just now

Review of 63 documents on antitachycardia pacing

63 documents

Documents reviewed concluded ATP is a good tool for interrupting ventricular arrhythmias2
4,016 matched pairs (8,032 patients)

8,032 patients

Patients compared in the matched device-database analysis of atrial ATP4
Single patient report; resolved by switching DDD to DDIR

130 bpm

Heart rate reached in the reported pacemaker-mediated tachycardia case3

The evidence behind it

5 sources
  • Other studies and data5

When it was published

Newest from 2026

20192026
Sources on this page by kind and year
SourceKindYear
Fundamentals of pacemakers ECG interpretation - part 2.Other studies and data2026
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyOther studies and data2021
Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmiasOther studies and data2019
ANTITACHYCARDIA PACING: OPTIMAL PROGRAMMING AND PREDICTION OF EFFICACY FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS. STATE OF THE ART AND PERSPECTIVE.Other studies and data2023
When the Pacemaker Goes Rogue: Pacemaker-Induced Tachycardia, Syncope, and Car Crash.Other studies and data2026

The community around it

No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.

Did this answer your question?

Be the first to vote
Your perspective belongs in the picture.Join free to vote

In brief

  1. A pacemaker senses the heart's own signals and paces when beats are too slow or conduction fails; programmed timing intervals and refractory periods determine exactly when it acts.1

    Evidence-backed
    Join free to vote
  2. For fast ventricular rhythms, ICDs can use antitachycardia pacing to interrupt the arrhythmia and avoid a shock, and good programming can reduce inappropriate or avoidable ATP.2

    Evidence-backed
    Join free to vote
  3. Reactive atrial-based ATP was associated with fewer longer-lasting atrial tachyarrhythmia/AF events (HR 0.56 for events of 30+ days) in a large matched device-database analysis.4

    Evidence-backed
    Join free to vote
  4. A pacemaker can itself cause a fast rhythm (PMT) by tracking retrograde atrial signals; in a reported case this produced 130 bpm tachycardia with severe hypotension and syncope, resolved by switching from DDD to DDIR.3

    Evidence-backed
    Join free to vote
  5. Many unusual ECG patterns — pseudo-Wenckebach, apparent AV block, abrupt rate drops — are normal consequences of device algorithms rather than malfunction.1

    Evidence-backed
    Join free to vote

Your turn

Have your say

See where others stand. Join free to add your perspective. One answer per account.

How do you feel about this?

No votes yet
Your perspective belongs in the picture.Join free to vote

Quick questions from connected pages

What it means for you

Which fits you?

Pick the situation closest to yours. Each answer says what it rests on.

If you see Wenckebach-like behaviour or a 2:1 pattern on a paced ECG

consider that upper rate behaviour of the device can mimic Mobitz type I or second-degree AV block, and check the programmed upper rate and timing intervals before calling it conduction disease.1

Evidence-backed

If an abrupt rate drop appears on a paced ECG

mode switching can cause abrupt rate drops that are misidentified as output failure; review the device's mode-switch settings and event log.1

Evidence-backed

If you notice a conspicuously short, fixed AV interval

this is the expected signature of ventricular safety pacing rather than a fault.1

Evidence-backed

If a patient with a pacemaker has recurrent fast rhythms with hypotension or syncope

PMT should be considered; in the reported case the fix was reprogramming from DDD to DDIR to prevent atrial tracking, and PVARP prolongation was not feasible because of slow ventriculoatrial conduction.3

Evidence-backed

If you are weighing therapies for fast ventricular rhythms in a patient with an ICD

ATP can interrupt ventricular arrhythmias and avoid shocks, and optimal ICD programming can reduce inappropriate or avoidable ATP therapies.2

Evidence-backed

If you are deciding whether to enable reactive atrial-based ATP

the available evidence is an association from a large device database (lower risk of atrial tachyarrhythmia/AF events of 1, 7 and 30+ days), not a randomised trial, so weigh it as supportive rather than definitive.4

Interpretation

If you are making device or programming decisions for an individual patient

treat these as clinical judgements for the care team, made with the patient and subject to current official guidance and device regulations.5

Evidence-backed

The full explanation

Interpretation AI-prepared starting map

An implanted pacemaker watches the heart's own electrical activity and delivers small electrical pulses when the heart beats too slowly or when conduction fails. For fast rhythms the picture splits: pacemakers and defibrillators can deliver antitachycardia pacing (ATP) — rapid bursts of pacing intended to interrupt an arrhythmia — and defibrillators can also shock; separately, a pacemaker can itself cause a fast rhythm (pacemaker-mediated tachycardia, PMT) when it tracks atrial signals that are conducted back up from the ventricles. How the device behaves in each case depends heavily on programmed timing intervals and refractory periods, which is why device-driven ECG patterns can mimic genuine arrhythmia or malfunction.123

What this rests on5 independent sources
  • Evidence 19
  • Interpretation 3

The full story · 3 chapters

01

Sensing the heart and pacing when it beats too slowly

AI summary:The device senses intrinsic signals and paces when beats are too slow, and many odd ECG patterns are normal results of its timing algorithms.

Evidence-backed

Evidence-backed: A pacemaker works by continuously monitoring the heart's intrinsic electrical signals and stepping in with pacing pulses when they are absent or too slow. The device's behaviour is governed by programmed timing intervals and refractory periods — the windows during which the device ignores signals or withholds pacing. Understanding these intervals is what lets a clinician tell programmed behaviour apart from true malfunction or a genuine arrhythmia.1

Evidence-backed

Evidence-backed: Several routine algorithms change what pacing looks like on an ECG without anything being wrong. Upper rate Wenckebach behaviour mimics Mobitz type I AV block, and a 2:1 upper rate response mimics second-degree AV block. Ventricular pacing minimization algorithms can produce isolated nonconducted P waves and prolonged AV intervals that look like conduction disease. Mode switching causes abrupt rate drops that can be mistaken for output failure, and ventricular safety pacing produces a conspicuously short, fixed AV interval. Rate and AV hysteresis produce pauses and wandering AV intervals that mimic oversensing or Wenckebach periodicity.1

Evidence-backed

Evidence-backed: Three discrete pacing artifacts can reflect AV-sequential cardiac resynchronization therapy (CRT), ventricular safety pacing in CRT, or His-bundle pacing with backup right-ventricular output. In each case the pattern is a product of the device's design and settings rather than a fault.1

02

What devices do when the heart beats too fast

AI summary:Devices can pace rapidly to interrupt fast rhythms, but a pacemaker can also itself cause a fast rhythm by tracking retrograde atrial signals.

Evidence-backed

Evidence-backed: For fast ventricular rhythms, antitachycardia pacing (ATP) is one of the therapies an implantable cardioverter defibrillator (ICD) provides. Successful ATP interrupts the arrhythmia and avoids a shock, and shocks are linked to increased mortality and morbidity — so avoiding them matters. A review of 63 documents concluded that ATP is a good tool for interrupting ventricular arrhythmias, and that optimal ICD programming can reduce inappropriate or avoidable ATP therapies. Better knowledge of the factors that predict whether ATP will work could also guide device choice and arrhythmic risk stratification.2

Evidence-backed

Evidence-backed: Pacemakers can also act on fast atrial rhythms. In a matched analysis from a large device database, 4,016 matched pairs (8,032 patients) were compared, and patients with reactive atrial-based ATP (rATP) enabled had significantly lower risks of atrial tachyarrhythmia/atrial fibrillation events lasting at least 1 day (hazard ratio 0.81), at least 7 days (HR 0.64) and at least 30 days (HR 0.56), all with P < 0.0001. The association held across age, sex, device type, baseline atrial tachyarrhythmia and preventive atrial pacing, and was independent of whether the patient had a pacemaker, defibrillator or resynchronization device.4

Evidence-backed

Evidence-backed: A pacemaker can also be the cause of a fast rhythm. In pacemaker-mediated tachycardia (PMT), the device tracks atrial signals that are conducted back up from the ventricles and paces the ventricles rapidly in response. In one reported case, atrial threshold testing provoked a PMT at 130 bpm with severe symptomatic hypotension (mean blood pressure below 50 mmHg), reproducible several times; given severe left ventricular systolic dysfunction and no other explanation, the PMT likely triggered syncope preceding a car accident. Management focused on reprogramming: the key change was a mode switch from DDD to DDIR to prevent atrial tracking, which terminated the PMT episodes. Prolonging the postventricular atrial refractory period (PVARP) was not possible because of very slow ventriculoatrial conduction. Follow-up showed no further PMT and no further presyncope or syncope.3

Evidence-backed

Evidence-backed: Distinguishing a device-driven fast rhythm from a true arrhythmia again comes down to timing intervals and refractory periods. Ventricular tachycardia is identified by a QRS morphology that diverges from the known paced pattern, absent pacing spikes and AV dissociation — features a clinician compares against the device's programmed behaviour.1

03

Why programming decides what the device does

AI summary:Mode, refractory periods and rate limits decide how the device behaves, and each setting leaves a recognisable signature on the ECG.

Interpretation

Interpretation: The same hardware behaves very differently depending on how it is programmed. Mode choice (for example DDD versus DDIR), refractory periods such as PVARP, upper rate limits, safety pacing and pacing-minimization algorithms all shape whether the device paces, tracks, withholds therapy or switches mode — and each leaves a recognisable signature on the ECG. The PMT case shows this directly: changing the mode to prevent atrial tracking stopped the tachycardias, while a PVARP-based fix was ruled out by the patient's slow ventriculoatrial conduction.31

Evidence-backed

Evidence-backed: Guidelines frame programming and device decisions as clinical judgements for the care team, made with the individual patient (and where appropriate their caregiver) in light of that patient's condition, and subject to updated official recommendations and device regulations. They do not override the treating professional's responsibility for individual decisions.5

Before you go

What to remember

Try to recall each hidden figure before you reveal it. Remembering, not rereading, is what makes it stick.

  1. A pacemaker can itself cause a fast rhythm (PMT) by tracking retrograde atrial signals; in a reported case this produced bpm tachycardia with severe hypotension and syncope, resolved by switching from DDD to DDIR.

  2. A pacemaker senses the heart's own signals and paces when beats are too slow or conduction fails; programmed timing intervals and refractory periods determine exactly when it acts.

  3. For fast ventricular rhythms, ICDs can use antitachycardia pacing to interrupt the arrhythmia and avoid a shock, and good programming can reduce inappropriate or avoidable ATP.

This answer keeps changing

When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 1 hour ago). Follow it to be told when that happens.

A portable medical monitor displaying vital signs with a yellow waveform on screenUp nextHow does a pacemaker keep the heart beating and how long does the battery last?How does a pacemaker keep the heart beating, and how long does its battery last?

Ask this Sylo

Still wondering about something?

Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.

Behind this page

Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.

Discussion

Nobody has added anything yet. If you have experience, evidence or a different view, you could be the first.

Sources

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

  1. 1
    Fundamentals of pacemakers ECG interpretation - part 2.
    Journal of electrocardiology (de et al.)Published Jul 14, 2026Checked Oct 17, 2026
    “Ventricular tachycardia is identified by QRS morphology diverging from the known paced pattern, absent pacing spikes, and AV dissociation. Upper rate Wenckebach behavior mimics Mobitz type I AV block; 2:1 upper rate response mimics second-degree AV block. Ventricular pacing minimization algorithms produce isolated nonconducted P waves and prolonged AV intervals that simulate pathological conduction disease. Mode switching causes abrupt rate drops misidentified as output failure. Ventricular safety pacing generates a conspicuously short, fixed AV interval. Three discrete pacing artifacts reflect AV-sequential cardiac resynchronization therapy (CRT), ventricular safety pacing in CRT, or His-bundle pacing with backup RV output. Rate and AV hysteresis produce pauses and wandering AV intervals mimicking oversensing or Wenckebach periodicity.ConclusionsRecognizing algorithm-driven ECG patterns requires knowledge of device timing intervals and refractory periods, which lets clinicians distinguish programmed behavior from true malfunction or cardiac arrhythmia.”
  2. 2
    ANTITACHYCARDIA PACING: OPTIMAL PROGRAMMING AND PREDICTION OF EFFICACY FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS. STATE OF THE ART AND PERSPECTIVE.
    Research paper (Avolio et al.)Published Jan 3, 2023Checked Oct 17, 2026
    “Introduction: Antitachycardia pacing (ATP) is one of the therapies provided by an implantable cardioverter defibrillator (ICD) for the treatment of ventricular arrhythmias (VA). Successful ATP leads to avoidance of shock, that is related to an increase in mortality and morbidity. Methods and Results : A total of 63 documents have been obtained by using the key term “Antitachycardia pacing” in PubMed, focusing on optimal ATP and ICD programing to reduce inappropriate or avoidable therapies, predictive factors of ATP efficacy and latest technologies and devices still in experimentation. Antitachycardia pacing confirms to be a good therapeutic tool to interrupt ventricular arrhythmias. An optimal ICD programming could lead to the reduction of inappropriate or avoidable ATP therapies. Furthermore, a better knowledge in predictive factors of ATP efficacy not only could better orient physicians on the device to implant, but also could allow for a better arrhythmic risk stratification.”
  3. 3
    When the Pacemaker Goes Rogue: Pacemaker-Induced Tachycardia, Syncope, and Car Crash.
    Case reports in cardiology (Grogg et al.)Published May 26, 2026Checked Oct 17, 2026
    “However, atrial threshold testing promptly provoked a PMT. The induced PMT led to a tachycardia of 130 bpm, causing severe symptomatic hypotension with a mean blood pressure falling below 50 mmHg. This could be easily reproduced several times. Given the patient's severe left ventricular systolic dysfunction and the absence of any overt alternative explanation, the PMT likely triggered the syncope preceding the car accident. Management focused on reprogramming the DR ICD. The most critical adaptation was a mode switch from DDD to DDIR to prevent atrial tracking, effectively terminating PMT episodes. A prolongation of the postventricular atrial refractory period (PVARP) was not possible due to the very slow VA conduction. The follow-up revealed no other episodes of PMT and the patient no longer experiences episodes of presyncope or syncope. This report highlights the potential for PMTs to induce severe hemodynamic instability and syncope, underscoring the importance of meticulous device evaluation.”
  4. 4
    Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmias
    Pacing and Clinical Electrophysiology (Crossley et al.)Published Apr 12, 2019Checked Oct 17, 2026
    “Of 43,440 qualifying patients, 4,203 had rATP on. Matching resulted in 4,016 pairs, totaling 8,032 patients for analysis. The rATP group experienced significantly lower risks of AT/AF events lasting ≥1 day (HR 0.81), ≥7 days (HR 0.64), and ≥30 days (HR 0.56) compared to control (P < 0.0001 for all). In subgroup analysis, rATP was associated with reduced risks of AT/AF events across age, sex, device type, baseline AT/AF, and preventive atrial pacing. Among real-world patients from a large device database, rATP therapy was significantly associated with a reduced risk of AT/AF. This association was independent of whether the patient had a pacemaker, defibrillator, or resynchronization device.”
  5. 5
    2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
    European Heart Journal (Glikson et al.)Published Aug 29, 2021Checked Oct 17, 2026
    “evant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgement, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.”

How it changed

Published 1 time since Oct 17, 2026.

  1. Version 2Oct 17, 2026Live now

    AI-prepared Starting Map from live research.

    • First published version.
Every version, side by side

Help improve it

The brief is open about what's uncertain. These are the specific gaps that new material would fill.

  • “Sensing the heart and pacing when it beats too slowly” rests on one independent source

    A second, independent source that confirms or challenges it would make this part more reliable.

Open questions

  • Which patient and arrhythmia characteristics best predict whether antitachycardia pacing will successfully stop a ventricular arrhythmia rather than fail and require a shock?

    No answers yet

  • How often does pacemaker-mediated tachycardia cause severe symptoms such as syncope, and which programming strategies most reliably prevent it?

    No answers yet

  • Does reactive atrial-based ATP itself reduce atrial fibrillation, or is its association with fewer events explained by other differences between patients whose devices had it enabled?

    No answers yet

Around this topic

Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.

Ask this Sylo

Answers only from “How does a pacemaker work and what does it do when the heart beats too fast?”

Ask anything about this page. The AI reads only its reviewed brief, sources and contributions, cites what it used, and says when the page doesn't cover something.